Primary testicular diffuse large B-cell lymphoma with gonadal vein tumor thrombus: A case report and review of the literature.

IF 3.6 Q3 ONCOLOGY
Yu-Zhi Zuo, Zhen Liang, Bo-Ju Pan, Wei-Gang Yan, Zhi-En Zhou
{"title":"Primary testicular diffuse large B-cell lymphoma with gonadal vein tumor thrombus: A case report and review of the literature.","authors":"Yu-Zhi Zuo, Zhen Liang, Bo-Ju Pan, Wei-Gang Yan, Zhi-En Zhou","doi":"10.5306/wjco.v16.i11.111527","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Primary testicular lymphoma (PTL) is a rare, aggressive malignancy, representing a small fraction of testicular tumors and non-Hodgkin lymphomas, yet it is the most common testicular malignancy in older men. Diffuse large B-cell lymphoma (DLBCL), which is typically the aggressive subtype, dominates PTL and shows diffuse B-cell infiltration. Venous tumor thrombus, uncommon in lymphomas, is uniquely reported in this case of testicular DLBCL with gonadal vein involvement.</p><p><strong>Case summary: </strong>A 62-year-old man presented with a two-month history of painless left testicular swelling and stiffness. Diagnostic imaging [ultrasonography, computed tomography (CT), and <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/CT (<sup>18</sup>F-FDG-PET/CT)] revealed bilateral testicular masses and a gonadal vein tumor thrombus (SUVmax 16.5). Left orchiectomy confirmed DLBCL with CD20, Bcl-2, and MUM1 positivity (Ki-67: approximately 80%). The disease was staged as Ann Arbor stage IVA (International Prognostic Index score 3, high-intermediate risk). The patient received Rituximab, Polatuzumab Vedotin, Cyclophosphamide, Epirubicin, and Prednisolone chemotherapy, completing the first cycle with good tolerability. No adverse events were reported, and follow-up is ongoing to assess long-term outcomes. This case highlights the diagnostic utility of <sup>18</sup>F-FDG-PET/CT and the importance of multidisciplinary management in rare PTL presentations with tumor thrombus.</p><p><strong>Conclusion: </strong>This case demonstrates the diagnostic complexities of PTL with gonadal vein tumor thrombus, underscoring the importance of considering lymphoma in elderly patients with testicular masses and venous involvement. A multi-disciplinary team including urologists, hematologists, and radiation oncologists is needed to ensure appropriate therapy.</p>","PeriodicalId":23802,"journal":{"name":"World journal of clinical oncology","volume":"16 11","pages":"111527"},"PeriodicalIF":3.6000,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12678962/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of clinical oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5306/wjco.v16.i11.111527","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Primary testicular lymphoma (PTL) is a rare, aggressive malignancy, representing a small fraction of testicular tumors and non-Hodgkin lymphomas, yet it is the most common testicular malignancy in older men. Diffuse large B-cell lymphoma (DLBCL), which is typically the aggressive subtype, dominates PTL and shows diffuse B-cell infiltration. Venous tumor thrombus, uncommon in lymphomas, is uniquely reported in this case of testicular DLBCL with gonadal vein involvement.

Case summary: A 62-year-old man presented with a two-month history of painless left testicular swelling and stiffness. Diagnostic imaging [ultrasonography, computed tomography (CT), and 18F-fluorodeoxyglucose positron emission tomography/CT (18F-FDG-PET/CT)] revealed bilateral testicular masses and a gonadal vein tumor thrombus (SUVmax 16.5). Left orchiectomy confirmed DLBCL with CD20, Bcl-2, and MUM1 positivity (Ki-67: approximately 80%). The disease was staged as Ann Arbor stage IVA (International Prognostic Index score 3, high-intermediate risk). The patient received Rituximab, Polatuzumab Vedotin, Cyclophosphamide, Epirubicin, and Prednisolone chemotherapy, completing the first cycle with good tolerability. No adverse events were reported, and follow-up is ongoing to assess long-term outcomes. This case highlights the diagnostic utility of 18F-FDG-PET/CT and the importance of multidisciplinary management in rare PTL presentations with tumor thrombus.

Conclusion: This case demonstrates the diagnostic complexities of PTL with gonadal vein tumor thrombus, underscoring the importance of considering lymphoma in elderly patients with testicular masses and venous involvement. A multi-disciplinary team including urologists, hematologists, and radiation oncologists is needed to ensure appropriate therapy.

原发性睾丸弥漫性大b细胞淋巴瘤伴性腺静脉肿瘤血栓1例并文献复习。
背景:原发性睾丸淋巴瘤(PTL)是一种罕见的侵袭性恶性肿瘤,仅占睾丸肿瘤和非霍奇金淋巴瘤的一小部分,但它是老年男性最常见的睾丸恶性肿瘤。弥漫大b细胞淋巴瘤(DLBCL)是典型的侵袭性亚型,以PTL为主,表现为弥漫b细胞浸润。静脉肿瘤血栓在淋巴瘤中不常见,在睾丸DLBCL伴性腺静脉受累的病例中有独特的报道。病例总结:一名62岁男性,有两个月的无痛性左睾丸肿胀和僵硬史。诊断影像学[超声、计算机断层扫描(CT)和18f -氟脱氧葡萄糖正电子发射断层扫描/CT (18F-FDG-PET/CT)]显示双侧睾丸肿块和性腺静脉肿瘤血栓(SUVmax 16.5)。左睾丸切除术证实DLBCL伴CD20、Bcl-2和MUM1阳性(Ki-67:约80%)。疾病分期为Ann Arbor期IVA(国际预后指数评分3分,高-中危)。患者接受利妥昔单抗、Polatuzumab Vedotin、环磷酰胺、表柔比星、强的松龙化疗,完成第一个周期,耐受性良好。未报告不良事件,正在进行随访以评估长期结果。本病例强调了18F-FDG-PET/CT的诊断价值,以及多学科治疗对罕见PTL合并肿瘤血栓的重要性。结论:本病例显示了PTL伴性腺静脉肿瘤血栓的诊断复杂性,强调了老年睾丸肿块伴静脉受累患者考虑淋巴瘤的重要性。需要一个包括泌尿科医生、血液科医生和放射肿瘤科医生在内的多学科团队来确保适当的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
585
期刊介绍: The WJCO is a high-quality, peer reviewed, open-access journal. The primary task of WJCO is to rapidly publish high-quality original articles, reviews, editorials, and case reports in the field of oncology. In order to promote productive academic communication, the peer review process for the WJCO is transparent; to this end, all published manuscripts are accompanied by the anonymized reviewers’ comments as well as the authors’ responses. The primary aims of the WJCO are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in oncology. Scope: Art of Oncology, Biology of Neoplasia, Breast Cancer, Cancer Prevention and Control, Cancer-Related Complications, Diagnosis in Oncology, Gastrointestinal Cancer, Genetic Testing For Cancer, Gynecologic Cancer, Head and Neck Cancer, Hematologic Malignancy, Lung Cancer, Melanoma, Molecular Oncology, Neurooncology, Palliative and Supportive Care, Pediatric Oncology, Surgical Oncology, Translational Oncology, and Urologic Oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书